PT101077A - Processo para a preparacao de derivados de tiazolidinodiona susbtituidos - Google Patents

Processo para a preparacao de derivados de tiazolidinodiona susbtituidos

Info

Publication number
PT101077A
PT101077A PT101077A PT10107792A PT101077A PT 101077 A PT101077 A PT 101077A PT 101077 A PT101077 A PT 101077A PT 10107792 A PT10107792 A PT 10107792A PT 101077 A PT101077 A PT 101077A
Authority
PT
Portugal
Prior art keywords
formula
pharmaceutically acceptable
compound
thiazolidinodiona
susceptible
Prior art date
Application number
PT101077A
Other languages
English (en)
Other versions
PT101077B (pt
Inventor
Richard Mark Hindley
Stefan Ronald Woroniecki
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of PT101077A publication Critical patent/PT101077A/pt
Publication of PT101077B publication Critical patent/PT101077B/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/04Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D277/06Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/14Nitrogen or oxygen as hetero atom and at least one other diverse hetero ring atom in the same ring
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/16Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing two or more hetero rings
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/8215Microorganisms
    • Y10S435/911Microorganisms using fungi

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Epoxy Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Catalysts (AREA)
  • Saccharide Compounds (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
PT101077A 1991-11-19 1992-11-19 Processo para a preparacao de derivados de tiazolidinodiona susbtituidos PT101077B (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB919124513A GB9124513D0 (en) 1991-11-19 1991-11-19 Novel process

Publications (2)

Publication Number Publication Date
PT101077A true PT101077A (pt) 1994-02-28
PT101077B PT101077B (pt) 2000-09-29

Family

ID=10704843

Family Applications (1)

Application Number Title Priority Date Filing Date
PT101077A PT101077B (pt) 1991-11-19 1992-11-19 Processo para a preparacao de derivados de tiazolidinodiona susbtituidos

Country Status (19)

Country Link
US (2) US5726055A (pt)
EP (2) EP0905255A3 (pt)
JP (1) JP3782099B2 (pt)
KR (2) KR100270133B1 (pt)
AT (1) ATE181114T1 (pt)
AU (3) AU673145B2 (pt)
CA (1) CA2123782A1 (pt)
DE (1) DE69229402T2 (pt)
DK (1) DK0615549T3 (pt)
ES (1) ES2132135T3 (pt)
GB (1) GB9124513D0 (pt)
GR (1) GR3031029T3 (pt)
HK (1) HK1012423A1 (pt)
MX (1) MX9206679A (pt)
NZ (1) NZ245182A (pt)
PT (1) PT101077B (pt)
TW (1) TW240249B (pt)
WO (1) WO1993010254A1 (pt)
ZA (1) ZA928937B (pt)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE39384E1 (en) 1993-09-01 2006-11-07 Smithkline Beecham P.L.C. Substituted thiazolidinedione derivatives
GB9723295D0 (en) * 1997-11-04 1998-01-07 Smithkline Beecham Plc Novel process
US7091359B2 (en) 1997-11-04 2006-08-15 Smithkline Beecham Plc Process for the preparation of thiazolidinedione derivatives
CA2311125C (en) 1997-11-19 2011-01-18 Takeda Chemical Industries, Ltd. Apoptosis inhibitor
GB9726563D0 (en) * 1997-12-16 1998-02-11 Smithkline Beecham Plc Novel pharmaceutical
GB9726568D0 (en) 1997-12-16 1998-02-11 Smithkline Beecham Plc Novel pharmaceutical
US6664278B2 (en) 1997-12-16 2003-12-16 Smithkline Beecham P.L.C. Hydrate of 5-[4-[2-(N-methyl-N-(2-pyridil)amino)ethoxy]benzyl]thiazolidine-2,4-dione maleic acid salt
US20020137940A1 (en) 1997-12-16 2002-09-26 Smithkline Beecham P.L.C. 5-[4-[2-(N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2, 4-dione, maleic acid salt, hydrate as pharmaceutical
HUP0200929A3 (en) 1999-04-23 2004-03-29 Smithkline Beecham Plc Thiazolidinedione derivative and its use as antidiabetic and process for preparation thereof
PE20010044A1 (es) 1999-04-23 2001-03-10 Smithkline Beecham Plc Polimorfo de sal del acido maleico de 5-[4-[2-(n-metil-n-(2-piridil)amino)etoxi]bencil]-tiazolidina-2,4-diona
US20040248945A1 (en) 1999-04-23 2004-12-09 Smithkline Beecham P.L.C. Thiazolidinedione derivative and its use as antidiabetic
HU225919B1 (en) * 1999-12-18 2007-12-28 Richter Gedeon Nyrt Thiazolidine-derivatives, process for their preparation pharmaceutical and intermediates
GB0006133D0 (en) * 2000-03-14 2000-05-03 Smithkline Beecham Plc Novel pharmaceutical
GB0021865D0 (en) * 2000-09-06 2000-10-18 Smithkline Beecham Plc Novel pharmaceutical
GB0023970D0 (en) * 2000-09-29 2000-11-15 Smithkline Beecham Plc Novel pharmaceutical
GB0023971D0 (en) * 2000-09-29 2000-11-15 Smithkline Beecham Plc Novel pharmaceutical
EP1291436A1 (en) * 2001-09-11 2003-03-12 Bayer Ag Process for the stereoselective preparation of functionalized vicinal diols
CZ297347B6 (cs) * 2004-09-21 2006-11-15 Zentiva, A. S. Zpusob prípravy rosiglitazonu
WO2012153312A1 (en) 2011-05-11 2012-11-15 Ranbaxy Laboratories Limited Process for the purification of pioglitazone

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5522636A (en) * 1978-08-04 1980-02-18 Takeda Chem Ind Ltd Thiazoliding derivative
DE3001303A1 (de) * 1980-01-16 1981-07-23 Basf Ag, 6700 Ludwigshafen Optisch aktive phenylpropan-derivate, ihre herstellung und verwendung
AR240698A1 (es) * 1985-01-19 1990-09-28 Takeda Chemical Industries Ltd Procedimiento para preparar compuestos de 5-(4-(2-(5-etil-2-piridil)-etoxi)benzil)-2,4-tiazolidindiona y sus sales
DK173350B1 (da) * 1985-02-26 2000-08-07 Sankyo Co Thiazolidinderivater, deres fremstilling og farmaceutisk paæparat indeholdende dem
US4857468A (en) * 1985-04-13 1989-08-15 Kanegafuchi Kagaku Kogyo Kabushiki Kaisha Process for preparing optically active 2-halo-1-phenyl ethanol
US5232925A (en) * 1987-09-04 1993-08-03 Beecham Group P.L.C. Compounds
EP0842925A1 (en) * 1987-09-04 1998-05-20 Beecham Group Plc Substituted thiazolidinedione derivatives
US5143930A (en) * 1990-02-07 1992-09-01 Sankyo Company, Limited Thiazolidine derivatives with anti-diabetic activity, their preparation and their use

Also Published As

Publication number Publication date
EP0615549A1 (en) 1994-09-21
ZA928937B (en) 1994-03-17
US5726055A (en) 1998-03-10
US20020106762A1 (en) 2002-08-08
ATE181114T1 (de) 1999-06-15
JP3782099B2 (ja) 2006-06-07
CA2123782A1 (en) 1993-05-27
EP0905255A2 (en) 1999-03-31
GB9124513D0 (en) 1992-01-08
EP0905255A3 (en) 1999-04-14
ES2132135T3 (es) 1999-08-16
TW240249B (pt) 1995-02-11
JPH07503129A (ja) 1995-04-06
AU673145B2 (en) 1996-10-31
MX9206679A (es) 1993-05-01
GR3031029T3 (en) 1999-12-31
DK0615549T3 (da) 1999-11-15
AU2949492A (en) 1993-06-15
DE69229402D1 (de) 1999-07-15
WO1993010254A1 (en) 1993-05-27
EP0615549B1 (en) 1999-06-09
DE69229402T2 (de) 1999-11-25
AU6572896A (en) 1996-12-12
NZ245182A (en) 1995-09-26
HK1012423A1 (en) 1999-07-30
KR100270133B1 (ko) 2000-10-16
PT101077B (pt) 2000-09-29
AU8954098A (en) 1999-01-14
KR20070108290A (ko) 2007-11-09

Similar Documents

Publication Publication Date Title
PT101077A (pt) Processo para a preparacao de derivados de tiazolidinodiona susbtituidos
HUT53368A (en) Process for producing pyrazolo-pyridine derivatives and pharmaceutical compositions containing them
CA2017076A1 (en) Alkoxyiminoacetamide derivatives and their use as fungicides
AU6129890A (en) Novel compounds
ES2031569T3 (es) Derivados de acidos quinolinocarboxilicos.
AT384424B (de) Verfahren zur herstellung von neuen 3-hydroxy-2-oxo-pyrrolidinderivaten und ihren salzen
FI101226B1 (fi) Menetelmä lääkeaineena käyttökelpoisten 2-[2-(karbonyyli)pyrrolidin-4-yylitio]-6-(1-hydroksietyyli)-1-metyylikarbapen-2-eemi-3-karboksyylihappojohdannaisten valmistamiseksi
ATE92489T1 (de) Imid-derivate, ihre herstellung und verwendung.
RU94033098A (ru) Способ производных 1-замещенного-5/4h/-тетразолинона
NO178025C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive (benzhydryloksyetylpiperidyl)alifatiske syrederivater
DE69130266D1 (de) Optisch wirksame Alkylendioxybenzolderivate und ihre Verwendung als Arzneimittel
CA2092919A1 (en) Epoxysuccinamic acid derivatives
DE3677857D1 (de) 2,5-dimethylpyrrolderivative, ihre herstellung und ihre verwendung.
CA2128202A1 (en) Alkyl Derivatives of Trazodone with CNS Activity
DE69332441D1 (de) Verfahren zur Herstellung von Halogenacetamidderivaten
ATE125256T1 (de) Zwischenprodukte der mureidomycin-gruppe, ihre herstellung und verwendung.
PT99250A (pt) Processo para a preparacao de derivados de piperazina
DE69008431D1 (de) Verfahren zur Herstellung von Imidazol-Derivaten.
ATE772T1 (de) Thiazolderivate, ihre herstellung und sie enthaltende arzneimittel.
DE69127846D1 (de) Stereoselektives Verfahren zur Herstellung von 2-Amino-Ethanol-Derivaten mit zentralanalgetischer Aktivität und Zwischenprodukten
ATE25680T1 (de) Verfahren zur herstellung von 4-amino-5-dialkoxy- methylpyrimidinderivaten.
ATE109454T1 (de) Catecholaminester.
ATE265212T1 (de) Verwendung von 4-acylaminopyridin derivaten zur herstellung eines medikaments für die behandlung von zerebrovaskulären erkrankungen
PT84760B (pt) Processo de preparacao de derivados de tiadiazinona, de seus intermediarios e de composicoes farmaceuticas

Legal Events

Date Code Title Description
BB1A Laying open of patent application

Effective date: 19930712

FG3A Patent granted, date of granting

Effective date: 20000605

MM3A Annulment or lapse

Free format text: LAPSE DUE TO NON-PAYMENT OF FEES

Effective date: 20021231